Consistent with the observed loss of AS with IFN-γ-deficient CAR T-cells, DC activation and tumor antigen uptake were lost if treatment was applied using IFN-γ−/− CAR T-cells (Figure S6H–K). Here, IFNG is linked to neoplasm.